Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Int J Mol Sci ; 23(23)2022 Nov 24.
Article de Anglais | MEDLINE | ID: mdl-36498981

RÉSUMÉ

The changes occurring in viral quasispecies populations during infection have been monitored using diversity indices, nucleotide diversity, and several other indices to summarize the quasispecies structure in a single value. In this study, we present a method to partition quasispecies haplotypes into four fractions according to their fitness: the master haplotype, rare haplotypes at two levels (those present at <0.1%, and those at 0.1−1%), and a fourth fraction that we term emerging haplotypes, present at frequencies >1%, but less than that of the master haplotype. We propose that by determining the changes occurring in the volume of the four quasispecies fitness fractions together with those of the Hill number profile we will be able to visualize and analyze the molecular changes in the composition of a quasispecies with time. To develop this concept, we used three data sets: a technical clone of the complete SARS-CoV-2 spike gene, a subset of data previously used in a study of rare haplotypes, and data from a clinical follow-up study of a patient chronically infected with HEV and treated with ribavirin. The viral response to ribavirin mutagenic treatment was selection of a rich set of synonymous haplotypes. The mutation spectrum was very complex at the nucleotide level, but at the protein (phenotypic/functional) level the pattern differed, showing a highly prevalent master phenotype. We discuss the putative implications of this observation in relation to mutagenic antiviral treatment.


Sujet(s)
Virus de l'hépatite E , Hépatite E , Ribavirine , Humains , Études de suivi , Mutagènes , Nucléotides , Quasi-espèce/génétique , Ribavirine/usage thérapeutique , SARS-CoV-2/génétique , Hépatite E/traitement médicamenteux , Virus de l'hépatite E/effets des médicaments et des substances chimiques , Virus de l'hépatite E/génétique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE